A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities

Human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 20% to 30% of breast cancers and various other types of cancers, which plays a vital role in the cancer progression. Monoclonal antibodies targeting Her2 are now used in the clinic to treat Her2 overexpression cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaoqiong, Chen, Siqi, Lin, Limin, Liu, Jiayu, Wang, Yanlan, Li, Yumei, Li, Qing, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852409/
https://www.ncbi.nlm.nih.gov/pubmed/29455083
http://dx.doi.org/10.1016/j.tranon.2018.01.024

Ejemplares similares

Ejemplares similares